---
title: Gentian acquires Getica for SEK 3.0 million
description: Gentian acquires Getica for SEK 3.0 million
---

Moss, 15 June 2023

Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic tests, is pleased to announce that it has entered into an agreement to acquire Getica AB from Erling Sundrehagen. Getica AB, located in Gothenburg Sweden, is currently offering antibody purification services exclusively to Gentian Diagnostics and is also a provider of diagnostics research & development services. The company currently has five employees.

With this acquisition, Gentian Diagnostics will secure critical production competence in an essential step in the manufacturing process and realize operational gains estimated to be approximately NOK 2.0 million from 2024. In addition, Gentian Diagnostics will gain access to unique R&D capabilities.

Under the agreement, Gentian Diagnostics will pay a cash consideration of SEK 3.0 million for Getica AB and closing is expected to take place in early July.

IR contact:

Njaal Kind, CFO and COO

[njaal.kind@gentian.no](mailto:njaal.kind@gentian.no)

+47 919 06 525 (mobile)

 

To see the announcement follow this link: [https://newsweb.oslobors.no/message/593293](https://newsweb.oslobors.no/message/593293)

### You may also read

[Jul 02, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-acquires-getica-for-sek-3.0-million#)

##### [Gentian Diagnostics: Invitation to presentation of second quarter results](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

Gentian Diagnostics ASA will present its second quarter 2026 results on 9 July 2026 at 09.00 CEST. The..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

[Jun 24, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-acquires-getica-for-sek-3.0-million#)

##### [ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

Amsterdam / Moss, 24 June 2026 ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

[May 29, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-acquires-getica-for-sek-3.0-million#)

##### [Mandatory notification of trade](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)

Moss, 29 May 2026 Gentian Diagnostics ASA ("Gentian") has today been notified that the following transaction..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)